Lifestance Health Group Inc logo

Lifestance Health Group Inc(LFST)

Today's top pick Today’s top pick
upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
4-STAR RATING
STRONG BUY
BUY for 13 days
PROFIT SINCE LAST BUY
+5.15% ▲
LAST CLOSE
$14.08
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for LFST

11/13/2026: LFST (4-star) is a STRONG-BUY. BUY for 13 days. Simulated Profits (5.15%). Updated daily EoD!

LifeStance Health Group is a national provider of outpatient mental health services, operating a hybrid model of in-person and virtual care. The company's main strength lies in its large network of employed clinicians and strong relationships with commercial insurance payers, which helps sustain steady patient volume. Its primary growth story centers on scaling this platform and potentially shifting toward value-based care models. However, investors must monitor significant risks, including clinician labor shortages, reliance on insurance reimbursements, and the need to achieve sustainable profitability. The stock may best suit growth-oriented investors willing to tolerate the volatility typical of healthcare services companies in their expansion phase.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company offers exposure to the rapidly growing mental health sector with a scalable, tech-enabled model.
Momentum investorMixed fitMomentum is conditional on consistent signs of margin expansion and patient volume growth.
Value investorWeak fitThe stock currently carries high growth expectations and lacks consistent positive earnings.
Dividend investorWeak fitThe company is in a growth phase and does not pay a dividend.
Low-risk investorWeak fitHigh volatility and the risks inherent in the healthcare services sector make this unsuitable for low-risk portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is susceptible to swings based on growth metrics and investor sentiment toward healthcare tech.
Valuation riskMedium / highGrowth stocks in this sector often face re-rating risks if growth slows or costs escalate.
Competition risk (Digital health platforms)Medium / highCompetition from tech-native platforms can pressure pricing and clinician retention.
Business qualityMediumWhile the platform is established, the reliance on high-cost human capital creates operational challenges.
Dividend incomeLow / noneThere is no dividend income to provide a buffer against stock price declines.
Execution riskHighScaling a large network of clinical professionals while maintaining high service standards is complex and resource-intensive.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.38B USD
Price to earnings Ratio 78.61
1Y Target Price 16.8
Price to earnings Ratio 78.61
1Y Target Price 16.8
Volume (30-day avg) 5.3M shares
Beta 1.3
52 Weeks Range 6.01 - 15.66
Updated Date 11/13/2026
52 Weeks Range 6.01 - 15.66
Updated Date 11/13/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.18

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 16.67%
Avg. Invested days 43
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
LFST receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
LFST has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+116.8%) and solid cash generation (FCF margin 7.7%) are partially offset by soft profitability (net margin 0.7%), modest insider ownership of 3.10%.

Financial Health Rating

★★★★★
LFST's financial health is supported by solid cash strength, including free-cash-flow generation (7.7% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is LFST's strongest growth driver at +116.8% FY2025 versus FY2024 (strong, 5 stars). Revenue growth (+13.9%, solid) and free-cash-flow growth (+28.4%, solid) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 93.6% and approximately 75.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 3.10% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

TPG GP A, LLC 29.39%
FMR Inc 15.32%
BlackRock Inc 9.56%
Summit Partners, LLP 4.37%
Vanguard Portfolio Management, LLC 3.67%

Unit Economics (Per $1K Revenue)

★★★★★
LFST generates approximately $324 of gross profit, $17 of operating income, and $77 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins explain the 2-star rating, with solid cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 21.84%

Quantitative Style Profile

★★★★★
LFST has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Mental Health ServicesFees from insurance payers and patients for therapy and psychiatric sessions.They generate revenue every time a patient visits one of their clinicians for care.

Earnings Date

Report Date 2026-11-05
When Before Market
Estimate 0.03
Actual 0.06

Profitability

Profit Margin 4.29%
Operating Margin (TTM) 6.43%

Management Effectiveness

Return on Assets (TTM) 3.11%
Return on Equity (TTM) 4.82%

Valuation

Trailing PE 78.61
Forward PE 62.5
Enterprise Value 5.71B
Price to Sales(TTM) 3.21
Enterprise Value 5.71B
Price to Sales(TTM) 3.21
Enterprise Value to Revenue 3.4
Enterprise Value to EBITDA 36.68
Shares Outstanding 380.19M
Shares Floating 288.34M
Shares Outstanding 380.19M
Shares Floating 288.34M
Percent Insiders 3.1
Percent Institutions 93.59

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.